Suppliers / Supernus Pharmaceuticals

Supernus Pharmaceuticals

United States 831 employees Updated 9 July 2026

Supernus Pharmaceuticals is a finished-dose manufacturer based in United States. It appears in 10 regulatory filings across 1 regulator, without an active US DMF or CEP on file.

0
active US DMFs
0
valid CEPs
0
registered plants
10
filings across 1 regulators

Filings and GMP by regulator

Regulator Filings GMP certificates
US FDA 10 None

Limited public record

Beyond the filing counts above, the public registers hold no plant, inspection or portfolio detail for this company as at 9 July 2026. We report that as a gap rather than inferring an answer.

Questions about Supernus Pharmaceuticals

Does Supernus Pharmaceuticals hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Supernus Pharmaceuticals. It does have 10 filings with one regulator, so it is registered, just not with the two strong registers buyers usually screen on.
Where does Supernus Pharmaceuticals file?
Filings are on record with US FDA, 10 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Supernus Pharmaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Aaa Pharmaceuticals also in United States Aarkish Pharmaceuticals NJ also in United States Abbott Laboratories also in United States Abon Pharmaceuticals also in United States Access Business Group also in United States

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability